Liver Cancer Rates Are Rising. Do You Know the Treatable Risk Factors?

Several health issues tied to liver disease can be managed or treated before they lead to cirrhosis or cancer. A Michigan Medicine liver specialist explains the connection.

7:00 AM

Author | Rene Wisely

Liver cancer diagnoses have more than tripled in the United States since 1980.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

The culprit? A perfect storm of treatable factors, one Michigan Medicine specialist says.

The prevalence of hepatitis C in baby boomers as well as spiking rates of obesity, diabetes and high cholesterol among all ages — is responsible, says Neehar Parikh, M.D., M.S., a clinical lecturer and medical director of the University of Michigan Comprehensive Cancer Center's Liver Tumor Program.

Many boomers don't know they have hepatitis C because screenings of donated blood and organs were not available until 1992.

And a rise in the latter health conditions, Parikh notes, is linked to an uptick in nonalcoholic fatty liver disease, or NAFLD, an accumulation of excess fat in the liver.

"These two trends have come to a head in the United States, so we're seeing more liver cancer as a result," he says.

Fortunately, hepatitis C and NAFLD have promising outcomes if caught early, before they can advance to cirrhosis or liver cancer.

Silent risks of liver disease

Hepatitis C is a curable virus that spreads when people share blood through the use of infected needles to inject illicit drugs, during sex or, although rare, during childbirth.

It kills more people in the United States than any other infectious disease, according to the Centers for Disease Control and Prevention.

But because symptoms seldom emerge in hepatitis C and NAFLD, patients may go undiagnosed for several decades. By then, scarring of the liver or cirrhosis may have occurred, which can lead to complications including liver cancer. Meanwhile, Parikh's recent research has found that as the nation's obesity rates rise, the number of patients with NAFLD-related liver disease and liver cancer is increasing rapidly.

Prevention of chronic liver disease: lifesaving knowledge

The two main types of liver cancer, in which the cancer begins in the liver cells themselves rather than spreading to the liver, are hepatocellular carcinoma (also called hepatoma, or HCC) and bile duct cancer, or cholangiocarcinoma.

SEE ALSO: How to Have a Healthy Liver

"These are highly morbid cancers we're talking about," Parikh says.

But, he adds, they don't have to be: "Awareness about the underlying conditions is the key."

That requires patients to be proactive.

"Ask for a hepatitis C screening from your primary care doctor if you are a baby boomer, were a drug user or partook in other risky behaviors," Parikh says. "Or ask to have a liver panel drawn if you have one of the diseases to which NAFLD is linked, like obesity or diabetes.

"With better recognition of chronic liver disease, we can prevent these liver cancer numbers from further increasing."

To make an appointment with Michigan Medicine's liver clinic, call 844-233-0433.


More Articles About: Digestive Health Liver Cancer Cirrhosis of the Liver Nonalcoholic fatty liver disease (NAFLD) Liver Disease Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Spilled pills next to a stethoscope and pile of cash
Health Lab
Drug pricing program improved prostate cancer treatment adherence
Socially vulnerable patients were more likely to stick with oral medications when treated at a hospital participating in 340B program, suggesting these hospitals may have more resources to help patients.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
Animated microscopic image of the glioblastoma's tumor microenvironment
Health Lab
New model of key brain tumor feature could help scientists understand how to develop new treatments
Model shows how oncostreams form and behave in brain tumors – and how to inhibit them
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.